In January, Novavax posted positive results for its UK trial, but it has yet to file for approval from the Medicines and Healthcare products Regulatory Agency (MHRA), saying it intends to do so in the next “couple of months”. The UK has ordered 60 million doses of the vaccine, due to be made in northeast England. Read More
https://news.yahoo.com/novavax-vaccine-trialists-offered-two-120044083.html